George R. Painter
Vorstandsvorsitzender bei Drug Innovation Ventures At Emory LLC
Profil
George R.
Painter was the founder of Chimerix, Inc. (founded in 2000) where he held the position of Director & Chief Scientific Officer from 2011 to 2012.
Dr. Painter is also the founder of Altesa BioSciences, Inc., Drug Innovation Ventures At Emory LLC.
Currently, Dr. Painter is the President & Chief Executive Officer at Emory Institute For Drug Development and a Director at Koronis Pharmaceuticals, Inc. Dr. Painter's former positions include Director-Research Process at Glaxo Wellcome, Inc., Director-Chemistry & Virology at Burroughs Wellcome, and Executive Vice President-Research & Development at Triangle Pharmaceuticals, Inc. Dr. Painter received his undergraduate, graduate, and doctorate degrees from Emory University.
Aktive Positionen von George R. Painter
| Unternehmen | Position | Beginn |
|---|---|---|
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Vorstandsvorsitzender | - |
| Drug Innovation Ventures At Emory LLC | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von George R. Painter
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIX, INC. | Gründer | 20.07.2012 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Gründer | - |
| Burroughs Wellcome | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von George R. Painter
| Emory University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| Burroughs Wellcome | |
Emory Institute For Drug Development
Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Health Technology |
| Drug Innovation Ventures At Emory LLC |
